ArticleCancer medicine2021

Mortality associated with the use of non-vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban.

Yu-Sheng Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.